Non-small-cell lung cancer (NSCLC) treatment has led to improved efficacy and compliance due to individual tailoring of the therapeutic options and the use of strategies based on both clinical ...

Panelists discuss decision-making in metastatic non–-small cell lung cancer (NSCLC) when molecular testing results are delayed, focusing on strategies to optimize treatment while awaiting results.

This guide will help you understand how NSCLC is treated, potential side effects, and how to navigate life beyond cancer.

THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...